chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was in for her physical visit on 11/9/21 and staff member gave patient a Pfizer vaccine that was drawn up on 9/8/21 at 3PM (it was left in the temperature controlled fridge overnight). She called and checked with the immunization champion at our facility and was instructed to immediately give another vaccine. Patient was immediately given another full Pfizer COVID-19 vaccine 15 minutes later (that was drawn up at 8:30 AM on 11/9/21) . After checking with Pfizer this dose should not have been given as it was an "extra dose" so patient was given 2 doses of Pfizer COVID-19 vaccine within 15 minutes. Patient called on 11/11/ 21 c/o of not feeling well. Patient was given appt and was evaluated. She was c/o of chills, sweats, arm pain, severe pain, "feeling drunk", and severe pain. There was mild sweling on the left arm where the 2nd vaccine was given as well. No finding on the patient's physical exam. She was given 3 days off of work.
This spontaneous report as received from a pharmacist refers to a 78 year old female patient. The patient's concurrent condition and historical condition were not reported. It was reported that the patient had no known drug reactions or allergies. On 12-SEP-2016 the patient was vaccinated with ZOSTAVAX (lot number and expiry date unspecified) (dosing regimen and frequency unknown). Concomitant therapies included LYRICA, ARMOUR THYROID and SINGULAIR. On approximately 21-SEP-2016 (reported as approximately two weeks ago), the patient experienced bronchitis. The patient visited a physician on an unspecified date and was prescribed Prednisone (manufacturer unknown) for the event of bronchitis. It was reported that at the time of this report the patient had not started taking Prednisone (manufacturer unknown). The outcome of bronchitis is unknown. Causality assessment was not provided by the reporter. There was no Product quality issue (PQC) involved. No further information was provided. Additional information has been requested.
2 days post vaccination onset of fatigue and "limb heaviness".  Sleeping for up to 18 hours. Pt was not pregnant at time of vaccine-confirmed.  Only PMH. Sx resolved after 1 week.
Patient had not received dose 2 yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose received on 7th January 2022).   On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  GSK receipt date: 02-Aug-2022 Reporter comment: Nobody every reminded patient to take second dose before 6 months.  The patient had not received second dose yet.  Education was provided. Referred to health care professional. Medical information phone number was given. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
COVID 19 Pfizer dose given beyond use date.  There were no signs or symptoms of side effects.  There was no treatment necessary.
Patient experienced significant muscle pain starting at 9pm 7/30/2020.  Low grade (99)fever throughout night.  Fever spiked to 101 F at 7am 7/31/2020. Patient using Tylenol 1000mg every 4-6 hrs. as needed
Positive for Covid 19; Pneumonia; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (Positive for Covid 19) and PNEUMONIA (Pneumonia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced COVID-19 (Positive for Covid 19) (seriousness criterion hospitalization) and PNEUMONIA (Pneumonia) (seriousness criterion hospitalization). The patient was hospitalized from sometime in March 2021 to 11-Mar-2021 due to COVID-19 and PNEUMONIA. At the time of the report, COVID-19 (Positive for Covid 19) and PNEUMONIA (Pneumonia) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided/unknown. Treatment for events included antibody therapy.  Very limited information regarding these events has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine.; Sender's Comments: Very limited information regarding these events has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine.
Start having symptoms September 1 after getting the JYNNEOS vaccine. Inability to breathe at times, feel like something was stuck in my throat x one week and neck pain.
Fever of 101, slight nausea, intense body ache (all over), headache.
Palpitations employee experienced afib Narrative:  employee states she was hospitalized with afib but info is not available and employee has retired
Erythema, edema, heat and tenderness KINRIX injection site (R) arm.
APX 24 HOURS AFTER RECEIVING DOSE #2 OF ANTHRAX .5CC IM. GIVEN LEFT DELTOID, PT COMPLAINED OF PAIN UP TO NECK AND DOWN ARM TO FINGERTIPS. WITH SOME NUMBNESS TO FINGERTIPS. DELTOID SL SWOLLEN AND RED, NON HOT, NO FEVER, NO ENLARGED AXILLARY NODES. PT SELF TREATED WITH 400MG IBUPROFEN, HELPED A BIT.
Rash on body from head to toe - BENADRYL PO q 6 hr and OTC CLARITIN.
MUSCLE ACHES; TIREDNESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced muscle aches, and tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle aches and tiredness was not reported. This report was non-serious.
On 5/2/05 Monday,at approximately 11:00 AM, Child was administered Varicella vaccine subcutaneously to Left arm.  She was also given DTaP (Left Thigh) and PCV(Right Thigh).  At 11:05AM, 5 minutes post administration of VZV vaccine child experienced a localized reaction which consisted of a 1/2 cm indurated wheel and linear erythema under bandaid of left arm.  There was no evidence of any reaction to the childs thighs where the other vaccines were also given.  Child appeared well oriented, alert, although crying and hugging mom.  There were no signs of any respiratory difficulties or generalized hives although as a precaution child was escorted to a pediatrician.  Approximately at 11:30AM the child was then treated with Epinephrine and Diphenhydramine.  30 minutes post treatment child appeared well, calm, with no evidence of erythema to left arm although the localized 1/2 cm wheal still remained.  Child was discharged home with mother with instructions to continue Diphenhydramine as needed as directed by pediatrician.  A phone follow up was made to mother by vaccine administrator today 5/3/05.  Mother stated child was doing much better, no evidence of any further adverse reactions such as hives or difficulty breathing.  Per mom, child was not administered any further doses of Diphenhydramine following yesterday's visit.  Mother informed nurse administrator to file VAERS.
Patient developed shortness of breath, fever, chills and was diagnosed COVID positive on July 3, 2021.  Patient was admitted to hospital and received tocilizumab and remdesivir.  He received dexamethasone however this caused him hallucinations.  He initially required oxygen however he was weaned off to roomair.  He did receive antibiotics for possible pneumonia which he has now completed.  Patient also takes Coumadin for atrial fibrillation.  On 7/12, he transitioned another Hospital for swing bed for reconditioning.  He was ultimately discharged to home to his nursing facility on 7/17.
Swelling  and redness in my left eye. Severe pressure on the left side of head.
Gout reaction and pain initially in left big toe. Gout pain in right side of right foot. and in joints of both thumbs. Continues and has increased after 2nd vaccination on 02/20/2021.
Approx 4 hrs following the administration of vax pt became pale & listless; This episode lasted for 30 min p/which pt was fine;
REAL DIZZY/REAL WEAK/COULD NOT BREATHE/THERE WAS SOMETHING PASSING BEHIND THE NOSE BONE TO THE THROAT LIKE BIG MUCOUS/COULD NOT GET UP DIZZY/LEFT EAR HURT/ LEFT EYE STY UPPER LID/DIARRHEA WITH MUCOUS HEADACHE ON THE HEAD BONE.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hiatal hernia" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.
SYMPTOMS BEGAIN APPROXIMATELY 10 HOURS AFTER INJECTION. ALL WERE PRETTY SEVERE FOR 24 HOURS. ABATED AFTER 36 HOURS GONE AFTER 48 HOURS INJECTION SITE PAIN TIREDNESS HEADACHE MUSCLE PAIN CHILLS FEVER NAUSEA FEELING UNWELL SWOLLEN LYMPH NODES IN UNDERARM OF INJECTION ARM DECREASED APPETITE
Nails have white blotches and are brittle  and breaking and have a upside down reddish moon. Tips are very white and lines/ ridges.
This case was reported by a consumer via call center representative and described the occurrence of cough aggravated in a patient who received DTPa (Reduced antigen). Concurrent medical conditions included cough (the patient suffered with cough for a week). On an unknown date, the patient received DTPa vaccine. On an unknown date, an unknown time after receiving DTPa vaccine, the patient experienced cough aggravated. On an unknown date, the outcome of the cough aggravated was unknown. It was unknown if the reporter considered the cough aggravated to be related to DTPa vaccine. Additional details were provided as follows: The patient was suffering with a cough a for a week and just received a tdap shot because he had removed a metal particle from his eye. The patient did not know how long ago he had a tetanus shot, but at the time of reporting, the cough seemed to be a little worse. The patient was asking whether the vaccine had anything to do with his cough worsening.
SLIGHTLY LIGHTHEADED, WANTED TO LEAVE, stating she had sx after the vaccine on 1/8. Sx of body aches, fatigue and diarrhea developed on 1/9 and resolved 1/11
pt recd vax & mom noticed appearance of rash on trunk @ 1PM-now inc in extent 2PM; urticarial rash on trunk; lungs clear, no edema of lips or tongue; DPh given;
Can not lift my arm as of 3/18 and excruciating pain nite of 16 and 17 . Extra strength Tylenol did not phase pain. Pain eased up on 3/18 but still minimum movement. Chills on 16 ,17.  Fainted on 3/17 at 3:30 a.m. when I went to get a drink of water.
I have had a dull headache for the last 3 weeks, starting on day 3. I also have neck pain where the neck meets my head. Sometimes my head feels numb, mostly behind my left ear and on top of my skull. My neck hurts more when I turn my head from side to side. My doctor prescribed muscle spasms and headaches, and a CAT scan.
Taken to MD on 20MAY91 w/fever; dx as bronchitis tx w/antibiotics; rechecked on 21MAY91;
Legal report of a male pt who experienced neurodevelopmental injuries coincident with Certiva. On an unreported date, the pt received Certiva vaccination. On an unreported date, the pt experienced severe neurodevelopmental injuries, which was considered medically significant (OMIC). Pertinent laboratory tests, diagnostic procedures, medical history or concomitant medication information was not provided. The pt was a child.
Fever 102, Irritable, Lethargic, Tylenol decreased temp to 100 degreefor 24- 36 hours.
Janssen COVID-19 Vaccine EUA  NO PAIN, just a weird sensation, can only describe as "bubbles" in both my legs: behind the knee and calf. Started the night of May 25th and I didn't think any of it cause I have always had "jumpy" legs when I'm falling asleep. But Then the sensation was getting more intense the night of May 26th so the morning of May 27th I went to the ER.
Received IM flu vac 12/3/07.  Approx 20-30 later developed wheeze sensation, difficulty breathing w/SOB while driving.  Took SL BENADRYL 25 mg w/some relief and repeated 15-20 min later while driving home.  1.5 hr later home somewhat better.  C/O wheeze feeling and not feeling right as if allergies triggered (ragweed) achy feeling and problems breathing.  She denied eating, drinking, ingestion of any type, no new perfumes, odors/smells, no new clothing, no stings/insect bites, windows were up driving as cold (December in Texas).  No medical care obtained.  Did contact command 12/4 and PCP 12/5/07 who recommended exemption to flu vaccine.  Symptoms: Dyspnea (shortness of breath), Wheezing.
Base on date submitted in database and related registries. Patient received expired COVID -19 vaccine dose .
AFTER GIVING THE SHOT, WHILE EXPLAINING THE AFTER CARE TO THE PATIENT AND HER MOM, (WHO WAS PRESENT IN THE CONSULTATION ROOM), WE NOTICED THE PATIENT WAS ABOUT TO PASS OUT. HER HEAD STARTED FALLING TO ONE SIDE, HER EYES ROLLED UP AND HER HEAD WENT BACK. HER FACE AND NECK COLOR TURNED RED . WE HELD AN ICE PACK TO HER NECK AND FOREHEAD , RAISED HER LEGS WITH AN ADDITIONAL CHAIR WHILE SUPPORTING HER HEAD AND BACK (RESTING IN THE CHAIR WHERE THE VACCINE WAS GIVEN). ONE RX TECH CALLED FOR MEDICAL HELP.  THE PATIENT WAS IN AND OUT OF CONSCIOUSNESS, HER MOUTH WAS DRY. SHE NODDED HER HEAD FOR SOME WATER WHICH SHE TOOK SIPS OF IN BETWEEN TAKING DEEP BREATHS, IN THE MEANTIME THE PARAMEDICS ARRIVED AND SPOKE TO HER TO FIGURE OUT HER CONDITION AND HOW IT HAPPENED. SHE WAS THEN TRANSPORTED VIA AN AMBULANCE TO THE ER  OF THE LOCAL HOSPITAL WHERE SHE WAS GIVEN FURTHER CARE.  IN ABOUT AN HOUR AND HALF, WE CHECKED WITH HER MOM WHO CONFIRMED THAT SHE WAS DOING MUCH BETTER AND HER COLOR WAS BACK
This spontaneous report as received from a healthcare worker refers to a 14 year old female patient. Patient had no relevant medical history and no known drug allergies. On 19 or 20 December 2012 the patient was vaccinated with, GARDASIL, 0.5 ml, vial, intramuscular for immunization. Lot number was not provided. No other co-suspects were reported. No concomitant medications were used. A few days after receiving GARDASIL the patient developed swelling of her hands, feet and face; joint pain in her fingers and knees; and rash on her back and arms. Patient's mother called physician's office. BENADRYL was given as treatment for the events. The outcome of the events was reported as recovering/resolving. The relatedness for swelling of hands and feet, swelling of face and joint pain in fingers and knees was not provided for GARDASIL. Additional information has been requested.
patient accidentally received a dose of Kinrix instead of Infanrix; patient accidentally received a dose of Kinrix instead of Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number F5492, expiry date 27-OCT-2024) for prophylaxis.   On 21-JUN-2023, the patient received Kinrix. On 21-JUN-2023, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: patient accidentally received a dose of Kinrix instead of Infanrix) and inappropriate age at vaccine administration (Verbatim: patient accidentally received a dose of Kinrix instead of Infanrix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-JUN-2023 A medical assistant called in to report that a patient accidentally received a dose of Kinrix instead of Infanrix and wished to know how to proceed.  They provided information about the vaccine, patient and event.  Medical information was solicited be sent via fax. The reporter consented to follow up.  The patient received Kinrix instead of Infanrix, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Nauseousness; fatigue; diarrhea; This is a spontaneous report from a contactable consumer reported for herself. A 28-year-old female patient (non-pregnant) received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number and expiry date were unknown), via an unspecified route of administration on the right arm on 31Jan2021 17:30 at a single dose for COVID-19 immunization. The patient has no other medical history. The patient has no known allergies to medications, food, or other products. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of the vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Feb2021 at 08:00, the patient experienced nauseousness, fatigue, and diarrhea. No treatment was received for the reported adverse events. The outcome of the events was unknown. The case has been considered non-serious.   Information on the lot number has been requested.
Client had her vaccine grabbed her throat, pinching her neck leaving bright red marks. Interpreter said she was short of breath. Taken to the monitoring room to lay down. PSO2 98%  heart rate 178, blood pressure 138/94. Reports through interpreter waves of being hot and being tired. Monitored client heart rate went down to 158 reporting still some shortness of breath. Continued to rest. Client then reporting via interpreter that she was cold. 0847 blood pressure 138/88, heart rate 124. remained tired and not feeling well enough to sit up.  Client then taken to ER via wheel chair for further evaluation.
Inflammation of entire body/ specifically lower body; Headaches; double vision; Low energy; Low sensation; Neck pain; Extreme foot pain; Nervousness; anger; This is a spontaneous report from a contactable consumer (patient, self-reported). A 33-year-pld male patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Lot number and Expiry date: unknown), dose 2 via an unspecified route of administration in the right arm, on 06May2021 at 17:00, as single for COVID-19 immunization in the pharmacy or drug store. The patient's medical history and concomitant medications were not reported. The patient had no allergies. The patient previously patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Lot number and Expiry date: unknown), dose 1 via an unspecified route of administration in the right arm, on 24Apr2021 at 11:00, as single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient did not receive any other medications within 2 weeks prior. On 17May2021 at 01:00, the patient had inflammation of entire body/ specifically lower body, headaches, double vision, low energy, low sensation, neck pain, extreme foot pain, nervousness, and anger. The outcome of the events were not recovered.  Information on the lot/batch number has been requested.